Mateon Therapeutics Inc (MATN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | MATN | AMGN | VRTX | REGN | BMY |
| Company | Mateon Therapeutics Inc | Amgen Inc | Vertex Pharmaceutic | Regeneron Pharmaceuticals | Bristol-Myers Squibb Company |
| Price Information | |||||
| Exchange | OTC US | NASDAQ | NASDAQ | NASDAQ | NYSE |
| Open | 0.2350 | 315.28 | 442.00 | 969.27 | 44.30 |
| High | 0.2700 | 315.28 | 446.10 | 982.77 | 44.30 |
| Low | 0.2210 | 310.37 | 440.35 | 966.00 | 43.73 |
| Last | 0.2600 | 312.47 | 445.21 | 982.29 | 44.03 |
| Change | +0.0200 | -2.25 | +4.57 | +14.31 | -0.08 |
| % Change | +8.33% | -0.71% | +1.04% | +1.48% | -0.18% |
| Volume | 108,000 | 1,974,200 | 1,382,400 | 386,500 | 15,787,900 |
| 20-Day Average Volume | 247,485 | 2,910,960 | 1,122,380 | 455,815 | 14,971,005 |
| Previous Close | 0.2400 | 314.72 | 440.64 | 967.98 | 44.11 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 0.2475 | 293.57 | 412.42 | 939.27 | 45.04 |
| 20-Day Raw Stochastic | 66.67% | 82.19% | 98.36% | 94.14% | 11.19% |
| 20-Day Relative Strength | 49.73% | 63.74% | 72.10% | 61.09% | 33.86% |
| Weighted Alpha | +49.69 | +38.84 | +33.13 | +30.85 | -34.28 |
| Today's Opinion | 56% Buy | 72% Buy | 72% Buy | 72% Buy | 100% Sell |
| Previous Opinion | 24% Buy | 72% Buy | 72% Buy | 72% Buy | 100% Sell |
| Last Month's Opinion | 56% Buy | 56% Sell | 8% Buy | 24% Buy | 72% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | -3.70% since 03/22/21 | +0.75% since 05/10/24 | +5.31% since 05/10/24 | +0.87% since 05/10/24 | -2.02% since 05/10/24 |
| Low | 0.2066 on 03/26/21 | 307.06 on 05/13/24 | 422.44 on 05/14/24 | 966.00 on 05/17/24 | 43.68 on 05/16/24 |
| High | 0.2800 on 03/23/21 | 321.44 on 05/15/24 | 446.10 on 05/17/24 | 988.96 on 05/15/24 | 45.72 on 05/14/24 |
| 1-Month | |||||
| %Chg | unch since 02/26/21 | +18.33% since 04/17/24 | +13.26% since 04/17/24 | +9.00% since 04/17/24 | -7.96% since 04/17/24 |
| Low | 0.1900 on 03/19/21 | 260.68 on 04/19/24 | 391.01 on 04/18/24 | 875.22 on 04/26/24 | 43.33 on 05/02/24 |
| High | 0.3000 on 03/01/21 | 322.60 on 05/03/24 | 446.10 on 05/17/24 | 988.96 on 05/15/24 | 49.56 on 04/22/24 |
| 3-Month | |||||
| %Chg | +18.18% since 12/28/20 | +10.14% since 02/16/24 | +5.45% since 02/16/24 | +3.61% since 02/16/24 | -11.69% since 02/16/24 |
| Low | 0.1900 on 03/19/21 | 260.68 on 04/19/24 | 391.01 on 04/18/24 | 875.22 on 04/26/24 | 43.33 on 05/02/24 |
| High | 0.3800 on 01/25/21 | 322.60 on 05/03/24 | 446.10 on 05/17/24 | 998.33 on 02/28/24 | 55.03 on 03/13/24 |
| 6-Month | |||||
| %Chg | +44.44% since 09/28/20 | +17.74% since 11/17/23 | +27.02% since 11/17/23 | +22.41% since 11/17/23 | -13.39% since 11/17/23 |
| Low | 0.1610 on 09/29/20 | 260.52 on 11/21/23 | 346.29 on 11/28/23 | 792.57 on 11/28/23 | 43.33 on 05/02/24 |
| High | 0.3800 on 01/25/21 | 329.72 on 02/05/24 | 448.40 on 01/30/24 | 998.33 on 02/28/24 | 55.03 on 03/13/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 23,462 | 167,619,840 | 114,887,776 | 108,234,592 | 89,253,208 |
| Shares Outstanding, K | 90,240 | 536,435 | 258,053 | 110,186 | 2,027,100 |
| Annual Sales | 0 | 28,190,000,000 | 9,869,200,000 | 13,117,200,000 | 45,006,000,000 |
| Annual Net Income | -6,640,000 | 6,717,000,000 | 3,619,600,000 | 3,953,600,000 | 8,025,000,000 |
| Last Quarter Sales | 0 | 7,447,000,000 | 2,690,600,000 | 3,145,000,000 | 11,865,000,000 |
| Last Quarter Net Income | -1,990,000 | -113,000,000 | 1,099,600,000 | 722,000,000 | -11,911,000,000 |
| 60-Month Beta | 1.33 | 0.60 | 0.39 | 0.17 | 0.45 |
| Per-Share Information | |||||
| Most Recent Earnings | N/A | 3.96 on 05/02/24 | 4.76 on 05/06/24 | 9.55 on 05/02/24 | -4.40 on 04/25/24 |
| Latest Earnings Date | 04/05/21 | 05/02/24 | 05/06/24 | 05/02/24 | 04/25/24 |
| Most Recent Dividend | N/A | 2.250 on 05/16/24 | N/A | N/A | 0.600 on 04/04/24 |
| Next Ex-Dividends Date | N/A | 05/16/24 | N/A | N/A | 04/04/24 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 16.89 | 29.26 | 26.08 | 42.01 |